Angiotensin-converting enzyme inhibitor attenuates myocardial fibrosis in diabetes mellitus by inhibiting connective tissue growth factor

Myocardial Fibrosis ◽

Connective Tissue Growth Factor ◽

Enzyme Inhibitor ◽

Tissue Growth ◽

Converting Enzyme

Inhibition of the angiotensin-converting enzyme decreases skeletal muscle fibrosis in dystrophic mice by a diminution in the expression and activity of connective tissue growth factor (CTGF/CCN-2)

Cell and Tissue Research ◽

10.1007/s00441-013-1642-6 ◽

2013 ◽

Vol 353 (1) ◽

pp. 173-187 ◽

Cited By ~ 50

Author(s):

María Gabriela Morales ◽

Daniel Cabrera ◽

Carlos Céspedes ◽

Carlos P. Vio ◽

Yaneisi Vazquez ◽

...

Keyword(s):

Skeletal Muscle ◽

Growth Factor ◽

Connective Tissue ◽

Tissue Growth ◽

Converting Enzyme ◽

Muscle Fibrosis ◽

Skeletal Muscle Fibrosis ◽

Dystrophic Mice ◽

Expression And Activity

Angiotensin-Converting Enzyme Inhibitor Suppresses Tubular Expression of Platelet-Derived Growth Factor and Attenuates Progression of Tubulo-Interstitial Fibrosis in a Nephrotic Mouse Model

Nephron ◽

10.1159/000045112 ◽

1998 ◽

Vol 79 (4) ◽

pp. 503-504 ◽

Cited By ~ 6

Author(s):

Shinya Mizuno ◽

Yoko Mizuno-Horikawa ◽

Munehiro Okamoto ◽

Tsutomu Kurosawa

Keyword(s):

Growth Factor ◽

Mouse Model ◽

Enzyme Inhibitor ◽

Interstitial Fibrosis ◽

Platelet Derived Growth Factor ◽

Converting Enzyme ◽

Converting Enzyme Inhibitor

Angiotensin-Converting Enzyme Inhibitor Use and Major Cardiovascular Outcomes in Type 2 Diabetes Mellitus Treated With the Dipeptidyl Peptidase 4 Inhibitor Alogliptin

Hypertension ◽

10.1161/hypertensionaha.116.07797 ◽

2016 ◽

Vol 68 (3) ◽

pp. 606-613 ◽

Cited By ~ 17

Author(s):

William B. White ◽

Craig A. Wilson ◽

George L. Bakris ◽

Richard M. Bergenstal ◽

Christopher P. Cannon ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitor

Modulation of in vivo cardiac hypertrophy with insulin-like growth factor-1 and angiotensin-converting enzyme inhibitor: relationship between change in myosin isoform and progression of left ventricular dysfunction

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(00)00769-5 ◽

2000 ◽

Vol 36 (2) ◽

pp. 635-642 ◽

Cited By ~ 10

Author(s):

Yoshitaka Iwanaga ◽

Yasuki Kihara ◽

Takeshi Yoneda ◽

Takeshi Aoyama ◽

Shigetake Sasayama

Keyword(s):

Growth Factor ◽

Cardiac Hypertrophy ◽

Left Ventricular Dysfunction ◽

Ventricular Dysfunction ◽

Enzyme Inhibitor ◽

Left Ventricular ◽

Converting Enzyme

Relation of Angiotensin-Converting Enzyme Inhibitor Treatment to Insulin-Like Growth Factor-1 Serum Levels in Subjects >65 Years of Age (the InCHIANTI Study)

The American Journal of Cardiology ◽

10.1016/j.amjcard.2005.11.089 ◽

2006 ◽

Vol 97 (10) ◽

pp. 1525-1529 ◽

Cited By ~ 30

Author(s):

Marcello Maggio ◽

Gian Paolo Ceda ◽

Fulvio Lauretani ◽

Marco Pahor ◽

Stefania Bandinelli ◽

...

Keyword(s):

Growth Factor ◽

Enzyme Inhibitor ◽

Serum Levels ◽

Insulin Like Growth Factor ◽

Converting Enzyme ◽

Converting Enzyme Inhibitor ◽

Inhibitor Treatment

The Balance of Connective Tissue Growth Factor and Brain Natriuretic Peptide Regulates Myocardial Fibrosis and Stiffness

Journal of Cardiac Failure ◽

10.1016/j.cardfail.2005.08.165 ◽

2005 ◽

Vol 11 (9) ◽

pp. S278

Author(s):

Norimichi Koitabashi ◽

Masashi Arai ◽

Midori Morita ◽

Shiro Hara ◽

Kazuo Niwano ◽

...

Keyword(s):

Growth Factor ◽

Connective Tissue ◽

Brain Natriuretic Peptide ◽

Natriuretic Peptide ◽

Myocardial Fibrosis ◽

Connective Tissue Growth Factor ◽

Tissue Growth

Impaired Vascular Reactivity in African-American Patients with Type 2 Diabetes Mellitus and Microalbuminuria or Proteinuria Despite Angiotensin-Converting Enzyme Inhibitor Therapy

The Journal of Clinical Endocrinology & Metabolism ◽

10.1210/jc.2005-1632 ◽

2006 ◽

Vol 91 (1) ◽

pp. 31-35 ◽

Cited By ~ 30

Author(s):

A. Jawa ◽

S. Nachimuthu ◽

M. Pendergrass ◽

S. Asnani ◽

V. Fonseca

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

African American ◽

Vascular Reactivity ◽

Enzyme Inhibitor ◽

Converting Enzyme

Angiotensin converting enzyme inhibitor therapy reduces the vascular oxidative state in normotensive patients with newly diagnosed type 2 diabetes mellitus

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(03)82335-5 ◽

2003 ◽

Vol 41 (6) ◽

pp. 285

Author(s):

Bobby V. Khan ◽

Rekha G. Menon ◽

Stamtios Lerakis

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Newly Diagnosed ◽

Oxidative State

Hypoglycemia Associated with the Administration of Angiotensin-Converting Enzyme Inhibitor in a Patient with Diabetes Mellitus.

Internal Medicine ◽

10.2169/internalmedicine.36.77 ◽

1997 ◽

Vol 36 (1) ◽

pp. 77

Author(s):

Hiromi SAKAGUCHI ◽

Shinya MAEDA ◽

Yasutomo FUKUNAGA ◽

Daisuke INOUE ◽

Hiroyuki KOSHIYAMA

Keyword(s):

Diabetes Mellitus ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Converting Enzyme Inhibitor

Increased Connective Tissue Growth Factor Relative to Brain Natriuretic Peptide as a Determinant of Myocardial Fibrosis

Hypertension ◽

10.1161/hypertensionaha.106.077537 ◽

2007 ◽

Vol 49 (5) ◽

pp. 1120-1127 ◽

Cited By ~ 88

Author(s):

Norimichi Koitabashi ◽

Masashi Arai ◽

Shinya Kogure ◽

Kazuo Niwano ◽

Atai Watanabe ◽

...

Keyword(s):

Growth Factor ◽

Connective Tissue ◽

Brain Natriuretic Peptide ◽

Natriuretic Peptide ◽

Myocardial Fibrosis ◽

Connective Tissue Growth Factor ◽

Tissue Growth